Tara Hurst
Programme Manager
Key publications
-
Drug and Therapy Development for Triple Negative Breast Cancer
Kendrekar P. et al, (2023), 1 - 306
-
Preface
Kendrekar P. et al, (2023), Drug and Therapy Development for Triple Negative Breast Cancer
Recent publications
-
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
-
Drug and Therapy Development for Triple Negative Breast Cancer
Kendrekar P. et al, (2023), 1 - 306
-
Human Endogenous Retroviruses in Triple-Negative Breast Cancer
Hurst TP. et al, (2023), Drug and Therapy Development for Triple Negative Breast Cancer, 93 - 101
-
Preface
Kendrekar P. et al, (2023), Drug and Therapy Development for Triple Negative Breast Cancer
-
Editorial: Unravelling the Role of HERVs in Cancer: Insights and New Targets for Therapy
Matteucci C. et al, (2022), Frontiers in Oncology, 12